Cargando…
Circulating miRNAs in Breast Cancer Diagnosis and Prognosis
SIMPLE SUMMARY: In the era of precision medicine, new tools for better management of breast cancer patients are still needed. From this perspective, circulating microRNA (miRNA), a small group of non-coding endogenous RNAs with a nucleotide length of 18–25, could be potentially appealing as diagnost...
Autores principales: | Cardinali, Barbara, Tasso, Roberta, Piccioli, Patrizia, Ciferri, Maria Chiara, Quarto, Rodolfo, Del Mastro, Lucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101355/ https://www.ncbi.nlm.nih.gov/pubmed/35565446 http://dx.doi.org/10.3390/cancers14092317 |
Ejemplares similares
-
Extracellular Vesicles as Biomarkers and Therapeutic Tools: From Pre-Clinical to Clinical Applications
por: Ciferri, Maria Chiara, et al.
Publicado: (2021) -
Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico
por: Álvarez-Hilario, Lissuly Guadalupe, et al.
Publicado: (2023) -
Circulating Exosomal miRNAs as Biomarkers for the Diagnosis and Prognosis of Colorectal Cancer
por: Alves dos Santos, Katiusse, et al.
Publicado: (2020) -
Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer
por: de Souza, Marilesia Ferreira, et al.
Publicado: (2017) -
Preconditioned Mesenchymal Stromal Cell-Derived Extracellular Vesicles (EVs) Counteract Inflammaging
por: Gorgun, Cansu, et al.
Publicado: (2022)